UNDERSTANDING THE PRODUCT AND ITS MARKET PRESENTED BY- SIDDHARTH SIKARIA
Dec 14, 2014
UNDERSTANDING THE PRODUCT AND ITS
MARKET
PRESENTED BY- SIDDHARTH SIKARIA
10/04/2023 Confidential 2
Contents
Market Market Types, Size, Volumes
Indian Pharmaceutical MarketProduct Life Cycle
Relaunching Strategies Expansion of Product Life Cycle
SWOT AnalysisBoston Consulting Group (BCG) Matrix
10/04/2023 Confidential 3
Who is a Marketer?
A Marketer is someone seeking a response (attention, purchase, vote, donation) from another party called the prospectMarketers are responsible for stimulating
demand for a company’s productMarketing managers seek to influence the
level, timing, and composition of the demand to meet the organisation objectives. Eight demand states are possible
10/04/2023 Confidential 4
These are:i. Negative Demand- consumers dislike a
product and may even pay a price to avoid itii. Non-existent Demand- consumers may be
unaware or uninterested about the productiii. Latent Demand- Consumers may share a
strong need that cannot be satisfied by an existing product. Marketers try to capture this demand and come out with newer and better products
iv. Declining Demand- Consumers begin to buy the product less frequently or not at all
10/04/2023 Confidential 5
v. Irregular Demand- consumers purchase vary on seasonal, monthly, daily or even an hourly basis
vi. Full Demand- consumers are adequately buying all products put into the market place
vii. Overfull Demand- too many consumers would like to buy the product that can be satisfied
viii.Unwholesome Demand- consumers may be attracted to products that have undesirable social consequences
10/04/2023 Confidential 6
What is Market?
Economist describe market as a collection of buyers and sellers who transact over a particular product or particular classMarketers use the term “Market” to cover various group of customers. The five basic markets are:a) Resource Marketb) Government Marketc) Manufacture Marketd) Intermediary Markete) Consumer Market
10/04/2023 7
Resource Market
Government Market
Manufacture Market
Intermediary Market
Consumer Market
Resources
Money
Resources
Money
Money
Goods and Services
Money
Goods and Services
ServiceMoney
Taxes Goods
10/04/2023 Confidential 8
Seller and buyer are connected by flows:a) Seller sends goods, service and
communication to the market.b) In return they receive money and informationc) There is an exchange of money for goods and
serviced) There is an exchange of information
10/04/2023 Confidential 9
Key Customer Market
A. Consumer Market- consumer good and services such as soft drinks and cosmetics spend a great deal of time trying to establish a superior brand
B. Business Market- companies selling business goods often face well-trained and well-informed professional buyers who are skilled in evaluating competitive edge
C. Global Markets- Companies face challenges and decisions regarding which country to enter, how to enter the country, how to adapt to their product/ services to the country, and how to price their product
D. Nonprofit and Governmental Markets- Companies selling to these markets have to price their product carefully because these organisation have limited purchasing power like churches, universities, charitable organisation and government agencies
10/04/2023 Confidential 10
Products
Product is the end result of a manufacturing process, to be offered to the marketplace to satisfy a need or want.
Anything that is offered to the market that customers can acquire, use, interact with, experience, or consume, to satisfy a want or need
Service is any act or performance that one party can offer to another that is essentially intangible and does not result in the ownership of anything. Its production may or maynot be tied to a physical thing. Manufacture, Retailer, Distributor can provide value added
service to differentiate themselves
10/04/2023 Confidential 11
Product Characteristic
Products that are marketed include:• Physical goods• Service• Experiences• Events• Persons• Places• Properties• Organizations• Information• Ideas
10/04/2023 Confidential 12
CORE PRODUCT FEATURE
Expected
GENERIC PRODUCT
EXPECTED PRODUCT
AUGUMENTED PRODUCT
POTENTIAL PRODUCT
10/04/2023 Confidential 13
AUGUMENTED PRODUCT FEATURE
PHYSICAL
LOGICAL
EMOTIONAL
10/04/2023 Confidential 14
CHARACTERSTIC OF A PHARMACEUTICAL PRODUCT
PRODUCT COMPONENTEFFICACYSAFETY
TOLERABLITYSPEED OF ACTION
QUALITYCOST
EASE OF USETEMPRATURE STABILITY
SHELF LIFEPAITENT EDUCATION
PHYSICIAN INFORMATIONMAIL DELIVERY
BRANDING
CORE VALUES AUGMENTED VALUES
10/04/2023 Confidential 15
Product Life Cycle
Product Life Cycle Curve
10/04/2023 17
Some other types of PLC curves
10/04/2023 Confidential 18
10/04/2023 Confidential 19
What is PLC?
Product life cycle, as the name suggests is the life cycle of a product which begins from the introduction phase, then there is the growth phase, then a steady phase and finally the decline phase.
Importance of PLC
A company’s positioning and differentiation strategy must change as the product, market and competitors change over the product life cycle (PLC). To say that a product has a life cycle is to assert four things:a) Products have limited lifeb) Product sales pass through distinct stage,
each posing different challenges, opportunities, and problems to the seller
contd…
c) Profits rise and fall at different stages of the product life cycle
d) Products require different marketing, financial, manufacturing, purchasing, and human resource strategies in each life-cycle stage.
10/04/2023 Confidential 22
Phases in Product Life Cycle
Most of the PLC curves are portrayed as bell shaped. The curve is divides basically into four stages:a) Introductionb) Growthc) Maturityd) Decline
10/04/2023 Confidential 23
10/04/2023 Confidential 24
Introduction Phase
A period of slow sales growth as the product is introduced in the market. Profits are nonexistent because of heavy expense of product introduction
10/04/2023 Confidential 25
A product’s sales revenue are small and exhibit a slow growth
The manufacturer is trying to gain product acceptance from the prescriber or patients
The overall marketing strategy is to attract the therapeutic area opinion leaders, who are essential in communicating the product’s benefit to their colleagues through the pyramid of influence cascade
The marketers need market data that help them define the product’s optimal targeting, positioning and profiling.
10/04/2023 Confidential 26
What the Marketers can do in this Phase....
In order to increase consumer awareness and willingness to buy the product, the following activities can be implemented:i. Offer clinical trial experienceii. Include physicians and patients in long term treatmentiii. Develop opinion leadersiv. Develop media spokesperson (such as successful patient
testimonial) v. Risk reductionvi. Adapt promotional mixvii. Sampling or couponingviii. Broaden product offeringix. Modify marketing channels
10/04/2023 Confidential 27
Contd..
Furthermore the ability to prescribe or buy can be increased by the following activities:i. Penetration pricingii. Adequate distributioniii. Liberal payment termsiv. Wholesaler consignment stocksv. Compatibility with existing medical supplies
and equipment's
10/04/2023 Confidential 28
Some terms related with phase I
Product Development- when a new product is introduced in the current therapeutic segment, the company is said to be active in product development, as opposed to entering a new therapeutic segment with an existing product- a strategy called new market extension.
Diversification- When a new product is introduced into a new therapeutic segment the company is pursuing a diversification approach
10/04/2023 Confidential 29
10/04/2023 Confidential 30
Growth Phase
Product’s sales revenue are moderate but rapidly growing and its profitability is increasing
Early adopters like the product, and additional consumers start buying the product
Marketers main objective is to expand the distribution and product line by offering new product benefit and forms
Increasing competition drives down the product price
10/04/2023 Confidential 31
Cont.…
Sales force is expanding, shifting it’s priority from the few medical specialist to a large number of family physicians or GP’s nationwide
10/04/2023 Confidential 32
Some steps taken by Marketers in Phase-II
During the growth stage, the marketers use several strategies to sustain rapid market growth:i. Improve product quality and add new product features and
stylingii. Add new models and flanker productsiii. Enters new market segmentiv. Shifts from product awareness advertising to product
preference advertising v. Lowers the price to attract the next layer of price sensitive
buyersvi. Increases distribution coverage and enters new distribution
channel
Product Life Cycle Curve
Confidential 34
Maturity phase
This phase is characterized by a stabilized sale performance with low cost and high profitsAt this stage: Marketer is occupied with maintaining the
products advantage Fighting new competitive new product launches
with new features and benefitsA full product line is now available offering a wide spectrum of product dosages, ROA and formulation
10/04/2023 Confidential 35
The Maturity phase is divided into three stages:a) Growth
sales growth rate starts to decline No new distribution channel to fill New competitive forces emerge
b) Stable Sales flatten on per capita basis because of market
saturation potential consumers have tried the products and the future
sales govern by population growth and replacement demand
c) Decaying maturity Absolute level of sales starts to decline, customers begin to
switching over to other products
10/04/2023 Confidential 36
10/04/2023 Confidential 37
Decline Phase
Sales decline for a number of reason Technological advancement Shifting consumer taste Increase domestic and foreign competition Increase price cuttingNow the pharmaceutical marketers are faced with the dilemma of harvesting the product or terminating the product or introducing a replacement
10/04/2023 Confidential 39
STRATEGY FOR MODIFYING EXISTING PRODUCT
10/04/2023 Confidential 40
10/04/2023 Confidential 41
Very often successful product life cycle needs to be prolonged, either because the product can continue to be a significant revenue making engine for the organisation or because the existing product pipeline does not guarantee a promising blockbuster in the near future
10/04/2023 Confidential 42
Aspirin
Aspirin market is about a centaury old. Early it was used as antipyretic-analgesic but lost its
market to paracetamol due to effective repositioning of paracetamol and due to certain side effects of aspirin
It was repositioned in the market with safer dosage forms such as Enteric Coated tablets, Buffered coated, Dispersible tablets.
Brands like Dispirin (Reckit Coleman), Microfine Aspro (Nicolas) succeeded while lesser known brands vanished from the market
10/04/2023 Confidential 43
Metronidazole
Flagyl of May & Baker was used in t/t of “Giardiasis” . They later found out its use in t/t of “amoebiasis” which was more prevalent in India.
The company launched aggressive promotion of “FLAGYL” in t/t of amoebiasis and replaced conventional treatment with emetine and dihydroemetine inj..
Many other companies joined the bandwagon and FLAGYL is among the top selling brands of May & Baker
10/04/2023 Confidential 44
Betamethasone
Betenesol injection had always been imp. Brand of Glaxo. It was lagging behind Decadron injection (Dexamethasone) (of Merind).
Glaxo by promoting its one new indication, i.e., a ten ampoule course in Myocardial Infraction, had changed the position dramatically
The product image as a life saving drug had got a big boost and product became a brand leader
10/04/2023 Confidential 45
Product Life can be extended by: Find out the new usage of the product Enter new markets by covering new geographical market or
expand the existing new market coverage Modify existing product, Introduce different size, Introduce
larger pack size of tonics and enzymes Introduce new flavours, New dosage Forms, Introduce
flanker products Keep track of competition and develop your products
constantly Be alert to spot the new opportunity and introduce the
new products early enough in your existing markets
10/04/2023 Confidential 46
SWOT ANALYSIS
10/04/2023 Confidential 47
What is SWOT analysis?
The overall evaluation of a company’s Strength, Weakness, Opportunities and Threats is called SWOT analysis. It is a way of monitoring the external and internal marketing environmental Internal Enviorment include Strength and
Weakness External Enviorment include Opportunities
and Threats
10/04/2023 Confidential 48
EXTERNAL ENVIORMENT
OPPORTUNITY- A marketing opportunity is an area of buyer need and interest that a company has high probability of profitably satisfying. There are three main source of market opportunity:a) To supply something that is short in marketb) To supply an existing product or service in a
new or superior wayc) To develop totally new product or service
10/04/2023 Confidential 49
Examples
A company may be able to offer a product at a much lower price. Pharmaceutical firms have created generic versions of brand-name drugs.
A company may be able to deliver a product or a service faster. Fed Ex discovered a way to deliver mail and packages much more quickly than the U.S Postal Service
A company can meet the need for more information and advice. Guru.com facilitates finding professional experts in a wide range of fields
10/04/2023 Confidential 50
Threats
An environmental threat is a challenge posed by an unfavorable trend or development that would lead, in the absence of a defensive marketing action, to lower sales or profit.
10/04/2023 Confidential 51
INTERNAL ENVIORMENT
The internal factors are those which are governed by the company themselves.
10/04/2023 Confidential 52
SWOT of Indian Pharma Industry
Strengths Cost effective technology Strong and well-developed manufacturing base Clinical research and trials Knowledge based, low- cost manpower in science & technology Proficiency in path-breaking research High-quality formulations and drugs High standards of purity Non-infringing processes of Active Pharmaceutical Ingredients (APIs) Future growth driver World-class process development labs Excellent clinical trial centres Chemical and process development competencies
10/04/2023 Confidential 53
Weaknesses Low Indian share in world pharmaceutical market
(about 2%) Lack of strategic planning Fragmented capacities Low R&D investments Absence of association between institutes and
industry Low healthcare expenditure Production of duplicate drugs
10/04/2023 Confidential 54
Opportunities Incredible export potential Increasing health consciousness New innovative therapeutic products Globalization Drug delivery system management Increased incomes Production of generic drugs Contract manufacturing Clinical trials & research Drug molecules
10/04/2023 Confidential 55
Threats Small number of discoveries Competition from MNCs Transformation of process patent to product
patent (TRIPS) Out-dated Sales and marketing methods Non-tariff barriers imposed by developed
countries
10/04/2023 Confidential 56
BOSTON CONSULTING GROUP (BCG ) MATRIX
10/04/2023 Confidential 57
This technique is particularly useful for multi-divisional or multi-product companies. The divisions or products compromise the organisations “business portfolio”. The composition of the portfolio can be critical to the growth and success of the company.The BCG matrix considers two variables, namely:a) MARKET GROWTH RATEb) RELATIVE MARKET SHARE
10/04/2023 Confidential 58
10/04/2023 Confidential 59
MARKET GROWTH RATE
The market growth rate is shown on the vertical (y) axis and is
expressed as a %. The range is set somewhat arbitrarily. The
overhead shows a range of 0 to 20% with division between low
and high growth at 10%. Inflation and/or Gross National Product have some impact on the range and thus the vertical axis can be modified to represent an index where the dividing line between low and high
growth is at 1.0. Industries expanding faster than inflation or GNP
would show above the line and those growing at less than inflation
or GNP would be classed as low growth and show below the line.
10/04/2023 Confidential 60
RELATIVE MARKET SHARE
The horizontal (x) axis shows relative market share. The share is calculated by reference to the largest competitor in the market. Again the range and division between high and low shares is arbitrary. The original work used a scale of 0.1, i.e. market leadership occurs when the relative market share exceeds 1.0.
10/04/2023 Confidential 61
The BCG growth/share matrix is divided into four cells or quadrants, each of which represent a particular type of business. These are:a) QUESTION MARKb) STARc) CASH COWSd) DOGS
Divisions or products are represented by circles. The size of the circle reflects the relative significance of the division/product to group sales. A development of the matrix is to reflect the relative profit contribution of each division and this is shown as a pie-segment within the circle.
10/04/2023 Confidential 62
10/04/2023 Confidential 63
QUESTION MARK
These are products or businesses, that compete in high growth markets but where the market share is relatively low. A new product launched into a high growth market and with an existing market leader would normally be considered as a question mark. Because of the high growth environment, they can be a “cash sink”.Strategic options for question marks include.. Market penetration Market development Product development Which are all intensive strategies or divestment.
10/04/2023 Confidential 64
STARSSuccessful question marks become stars. i.e. market leaders in high growth industries. However, investment is normally still required to maintain growth and to defend the leadership position. Stars are frequently only marginally profitable but as they reach a more mature status in their life cycle and growth slows, returns become more attractive. The stars provide the basis for long term growth and profitability.Strategic options for stars include.. Integration – forward, backward and horizontal Market penetration Market development Product development Joint ventures
10/04/2023 Confidential 65
CASH COWSThese are characterised by high relative market share in low growth industries. As the market matures the need for investment reduces. Cash Cows are the most profitable products in the portfolio. The situation is frequently boosted by economies of scale that may be present with market leaders. Cash Cows may be used to fund the businesses in the other three quadrants.It is desirable to maintain the strong position as long as possible and strategic options include.. Product development Concentric diversificationIf the position weakens as a result of loss of market share or market contraction then options would include..Retrenchment (or even divestment)
10/04/2023 Confidential 66
DOGS
These describe businesses that have low market shares in slow growth markets. They may well have been Cash Cows. Often they enjoy misguided loyalty from management although some Dogs
can be revitalised. Profitability is, at best, marginal.
Strategic options would include.. Retrenchment (if it is believed that it could be revitalised) Liquidation Divestment (if you can find someone to buy)
Successful products may well move from question mark though
star to Cash Cow and finally to Dog. Less successful products that
never gain market position will move straight from question mark to
Dog.
10/04/2023 Confidential 67
10/04/2023 Confidential 68
10/04/2023 Confidential 69
Advantages of BCG Matrix
The BCG is simple and useful technique for strategic analysis. It is convenient for multi-product or multi-divisional companies. It focuses on cash flow and is useful for investment and marketing decisions.
10/04/2023 Confidential 70
Limitations of BCG Matrix Definition (qualitative and quantitative) of the market is
sometimes difficult. It assumes that market share and profitability are directly related. The use of high and low to form four categories is too simplistic. Growth rate is only one aspect of industry attractiveness and high growth markets are not always the most profitable. It considers the product or business in relation to the largest
player only. It ignores the impact of small competitors whose market share is rising fast.
Market share is only one aspect of overall competitive position. It ignores interdependence and synergy.
10/04/2023 Confidential 71
Companies will frequently search for a balanced portfolio, since..Too many stars may lead to a cash crisisToo many Cash Cows puts future profitability
at riskAnd too many question marks may affect
current profitability.
10/04/2023 Confidential 72